High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma

B. Glass*, M. Ziepert, M. Reiser, M. Freund, L. Trümper, B. Metzner, A. Feller, M. Loeffler, M. Pfreundschuh, N. Schmitz

*Corresponding author for this work
28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences